Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelaic acid 20% versus anthralin 1% for scalp alopecia areata
IRCT20091012002581N8Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in alopecia areata comparing Anthralin 1% arm with Azelaic acid 20% arm (2 arms). Primary endpoint: Patient recovery rate. Started Jul 2022; status: completed.
02
Drugs
Azelaic aciddithranol
03
Conditions
alopecia areata
Beyond the preview
Go deeper on IRCT20091012002581N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002581N8.